Why is Mono Pharmacare falling/rising?

As of 05-Sep, Mono Pharmacare Ltd is currently priced at 22.50, with no change in price (0.00%). The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. Additionally, there has been a decline in investor participation, with delivery volume falling by 9.09% compared to the 5-day average. Over the past month, the stock has decreased by 6.83%, and year-to-date, it has dropped significantly by 35.06%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the stock's performance over the past week is flat at 0.00%, while the benchmark Sensex has increased by 1.29%. This indicates that Mono Pharmacare is underperforming compared to the broader market. Over the past month, while the stock has declined, the Sensex has shown a modest gain of 0.36%. The stark contrast between the stock's year-to-date decline of 35.06% and the Sensex's increase of 4.64% further highlights the challenges faced by Mono Pharmacare in the current market environment.